论文部分内容阅读
[目的]对注射用黄芪多糖联合EOF方案治疗晚期胃癌的疗效进行临床分析。[方法]将86例经病理学证实的晚期胃癌患者随机分为治疗组与对照组。对照组43例予以EOF方案化疗;治疗组43例除采用与对照组同等剂量EOF方案外,化疗时联合应用注射用黄芪多糖。观察2组的近期疗效、不良反应、生活质量、免疫功能变化。[结果]治疗组与对照组有效率分别为55.8%和41.9%,治疗组在提高疗效、减轻不良反应、提高生活质量、增强免疫功能方面均优于对照组。2组比较差异有统计学意义(P<0.05)。[结论]EOF方案联合注射用黄芪多糖治疗晚期胃癌可以提高疗效,减轻不良反应,增强免疫功能,提高生活质量。
[Objective] To analyze the efficacy of Astragalus polysaccharide injection combined with EOF regimen in the treatment of advanced gastric cancer. [Method] 86 cases of advanced gastric cancer confirmed by pathology were randomly divided into treatment group and control group. In the control group, 43 cases were treated with EOF regimen. In the treatment group, 43 cases were treated with the same dose of EOF regimen while in the control group. Astragalus polysaccharide was used in combination with chemotherapy. The two groups were observed the short-term efficacy, adverse reactions, quality of life, changes in immune function. [Results] The effective rates of the treatment group and the control group were 55.8% and 41.9% respectively. The treatment group was superior to the control group in improving the curative effect, alleviating adverse reactions, improving the quality of life and enhancing the immune function. The difference between the two groups was statistically significant (P <0.05). [Conclusion] EOF combined with APS in the treatment of advanced gastric cancer can improve curative effect, reduce adverse reactions, enhance immune function and improve quality of life.